Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment

Tumor necrosis factor receptor 2 (TNFR2) is expressed on some tumor cells, such as myeloma, Hodgkin lymphoma, colon cancer and ovarian cancer, as well as immunosuppressive cells. There is increasingly evidence that TNFR2 expression in cancer microenvironment has significant implications in cancer pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Hatamleh, Mohammad A. I., E.A.R., Engku Nur Syafirah, Boer, Jennifer C., Ferji, Khalid, Six, Jean-Luc, Chen, Xin, Elkord, Eyad, Plebanski, Magdalena, Mohamud, Rohimah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016661/
https://www.ncbi.nlm.nih.gov/pubmed/31877663
http://dx.doi.org/10.3390/cells9010033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016661/
https://www.ncbi.nlm.nih.gov/pubmed/31877663
http://dx.doi.org/10.3390/cells9010033

Ejemplares similares